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ABSTRACT 
Oxygen free radicals play an important role in the pathogenesis of tissue damage in many pathological conditions, 
including liver diseases. Aim of the present study focused on the investigation the possible relationship between serum 
malondialdehyde level, an index of lipid peroxidation, and ceruloplasmin levels, as protective agent against lipid 
peroxidation, in hepatitis C virus. A group of 31 hepatitis virus type C patients enrolled in the study, while; control group 
consisted of 25 healthy subjects. In the present study, total proteins (g/L), malondialdehyde (µM), ceruloplasmin oxidase 
activity (U/L) and ceruloplasmin concentration (g/L) were measured in sera samples of patients with hepatitis C virus as 
well as in the healthy controls.  
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INTRODUCTION 
Acute viral hepatitis is one of the most common infectious diseases[1], while hepatitis C virus (HCV) is the most  baleful 
form of acute viral hepatitis in many parts of the world [2  ], viral hepatitis is also a major health problem in Iraq. The most 
important causes of spreading the disease are low levels of socioeconomical status and poor hygiene conditions, 
particularly in countryside [3]. Hepatitis C mostly occurs in the context of community-wide epidemics during which infection 
is transmitted from person to person by the fecal-oral route[4]. 
Epidemically of   HCV may habit to hypothesis that HCV is one of the main causative agents of chronic viral hepatitis. 
Chronic hepatitis C can progress to cirrhosis and eventually to hepatocellular carcinoma over a period of 20 to 30 years 
[5]. The mechanisms which explain how HCV causes cell damage are not well understood, but symphoniouslly with the 
fact that liver is the central organ in the metabolism processes [6], one of the mechanisms including immunological liver 
damage, direct cytotoxicity mediated by different viral product and inductions of oxidative stress have been suggested as 
playing a pathogenic role in this infection,  It has been suggested that HCV may cause oxidative stress in infected cell 
[7,8]. 
Oxidative stress is defined as an imbalance between pro-oxidant and antioxidant mechanisms in our body, the balance 
being tilted in favor of the former, It has been unequivocally implicated in the pathogenesis and pathophysiology of many 
diseases [9]. Oxidative stress is associated with the disturbance of hepatocyte biochemistry and generation of ROS 
(reactive oxygen species), when the antioxidant defenses are critically lowered [10]. 
These ROS can damage cells by causing lipid peroxidation, and oxidative damage of DNA and proteins, and by depleting 
ATP stores. Prime targets of peroxidation by ROS are polyunsaturated fatty acids (PUFA) in membrane lipids. In the 
presence of metals (such as Fe 
3+
, Cu 
2+
), O
2.-
 can react with H2O
2
 to generate a hydroxyl radical than become even more 
reactive and cytototoxic than O
2.- 
or H2O2[8]. PUFA is degraded by free radicals to form malondialdehyde (MDA). The level 
of MDA in serum serves as a marker of cellular damage due to free radicals. Cells have multiple mechanisms to remove 
free radicals and thereby minimize tissue injury. Antioxidants such as enzymes, like: superoxide dismutase (SOD) and 
Ceruloplasmin (Cp), catalase (like: glutathione "GSH" ), and nutritional antioxidants(E and C vitamins) trap free radicals 
and act as free radical scavenging systems [11-13]. 
Aim of the present study focused on the investigation the possible relationship between serum malondialdehyde level, an 
index of lipid peroxidation, and ceruloplasmin levels, as protective agents against lipid peroxidation, in acute hepatitis C 
virus cases. 
MATERIALS AND METHODS 
Individuals of the Study  
The study group comprised 31 patients with newly diagnosed hepatitis C virus, between the age of 23-67 years who were 
admitted consecutively to the Liver and Digestive Tract Center of Al-Sader Medical City in Najaf, Iraq, between November 
2010 and June 2011. All patients were enrolled in the study before receiving the course of drugs. The patients group 
consisted of 17 females and 14 males and their range age was 44 years. The control group comprised 25 healthy 
individuals that included 12 females and 13 males aged between 19-62 (range of 43), the ratio of male to female was 
shown in Figure 1. 
 
Fig. 1: Gender Distribution of The Study Groups' Individuals 
All sera were collected in the morning after fasting 10 hour feature of the subjects in the present study are shown in the 
table 1. The healthy volunteers were selected on the basis of no alcoholic and smoking habits, without history of viral 
hepatitis, routing clinical check up during the entire period of research. Patients and control subjects residing in the same 
geographical area, and they were in the same socioeconomic status and similar diet habits. Patients with chronic hepatitis 
C diagnosed based on clinical, biochemical, histological and virological evidence in the same medical city. Blood samples 
were taken from subjects in accordance with standard procedure, 5 ml of blood was collected from vein and protected in 
evacuated tubes without anticoagulation agents. 
Determination of Total Serum Proteins Levels 
A total serum protein was estimated using Biuret method [14]. Biuret reagent supplied by the Manufacturing Company in a 
container contains 100 ml, that consist of sodium hydroxide (100 mM), sodium-potassium tartrate (16 mM), potassium 
iodide (15 mM), and cupric sulfate (6 mM). The bovine serum albumin was used as a standard protein. The procedure 
17 
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included mixing of 50 µl serum or standard with 2.5 ml Biuret reagent, then the mixture was incubated at room 
temperature for 30 minutes, and the absorbance  was measured at 540 nm. 
Measurement of Serum Malondialdehyde Level 
Malondialdehyde level is measured by the thiobarbituric acid-reacting
 
substances (TBARS) assay [15]. Abridgment,
 
150 µl 
of the serum sample was mixed with 1 ml of trichloro acetic acid (TCA) (17.5 %) and 1ml of thiobarbituric acid (0.6 %). 
Using the vortex, the final mixture was mix, the reaction mixture was then heated at 100°C
 
for 15 minutes in the water 
bath. After the mixture was cooled
 
with tap water, it was extracted with 1 ml TCA (70 %), the mixture was stand for 20 
minutes at 25°C, and centrifuged
 
at 3000 xg for 15 minutes. The organic
 
phase was measured by use of a 
spectrophotometer with a wavelength of 534 nm. 
Determination of Ceruloplasmin Oxidase activity 
The activity of ceruloplasmin oxidase was determined in serum using the modified Rice method [16]. The procedure 
included two glass tubes, test (A) and blank (B),  1ml of substrate buffer was added to each tube, then incubated at 37ºC 
for 5 min. A 100l of serum sample was added to tube A then incubated at 37ºC for 15 min. A volume of 3 ml of cold 
working inhibition solution was added to all of A and B tubes; at last 100l of deionized water was added to tube B. The 
absorbance was measured at λ=540 nm. 
Reagents 
Preparation of Substrate Buffer: Two gram of p-phenylenediamine was dissolved in the smallest volume of absolute 
ethanol, then filtered through double filter paper (Whitman  number 1). Gently and gradually, concentrated hydrochloric 
acid was added. The pink precipitate was filtered and washed with methanol, then the product salt (p-phenylenediamine-
2HCl) was dried at 70ºC. To purification of p-phenylenediamine-2HCl, the salt was dissolved in a minimum volume of hot 
water (60ºC), charcoal was added and left for 5 min, and then the mixture was filtered while hot. The purified salt was cold 
and precipitated from the filtrate by the addition of cold acetone until the turbidity was appeared (for the perfect results, all 
these step must be done in the ice bath). The mixture was refrigerated for several hours, filtered off the crystals, then it 
was dried in the dark in a vacuum desiccators over anhydrous calcium. To prepare substrate buffer, 0.1g of crystal p-
phenylenediamine-2HCl was dissolved in 100ml of acetate buffer (0.4M, pH 5.2, containing 0.4 M EDTA) 
Working Inhibition Solution: This solution was prepared by diluting 3 ml of stock inhibition solution (0.1 M of sodium 
azide and 0.5 M of sodium chloride) to 100 ml with deionized water, stored at 4ºC, and used cold [17]. 
Ceruloplasmin Oxidase Activity = The absorbance of A–B tubes×349.04 
Ceruloplasmin oxidase concentration was determined by measuring the absorbance of A and B tubes at wavelength = 605 
nm. 
Ceruloplasmin oxidase concentration = The absorbance of A–B tubes×87.5. 
Determination of Serum Copper and Iron Levels 
The levels of serum copper and iron were determined by flame atomic absorption spectrophotometry (GBC-933plus). 
 
Statistical Analysis 
The findings were expressed as the mean ± standard deviation (S.D.).
 
The data were analyzed with Student’s 
independent t test.
 
All statistical analyses were performed with the program Statistical
 
Package for the Social Science 
(SPSS for Windows, Version 19.0).
 
Pearson’s correlation was applied to determined the relations among the laboratory 
parameters of the present study, significance was determined regression. A p-value of <0.01 was accepted as statistically 
significant. 
RESULTS AND DISCUSSION 
In the current study, total proteins, malondialdehyde (µM), ceruloplasmin oxidase activity (U/L)  and ceruloplasmin 
concentration (g/L) were measured in sera samples of patients with acute hepatitis C virus as well as in the healthy 
controls. Table 1, shows that no significant variation (p =0.064) of total serum proteins' levels in patients with hepatitis C 
virus when compared with those of healthy individuals. On the other hand, the statistical evaluation failed to exhibit 
significant variation (p<0.001) for serum malondialdehyde when patients of hepatitis C virus were compared with those of 
healthy controls. With same manner, when the comparison was carried out for hepatitis C virus patients and control 
group, highly significant variations were found for ceruloplasmin oxidase activity and ceruloplasmin concentration 
(p<0.000 and p<0.001 for ceruloplasmin oxidase activity and ceruloplasmin concentration; respectively). Statistical 
analysis demonstrated a significant (p<0.001) variation of copper levels in hepatitis C virus patient group when compared 
with those in healthy individuals group. The same outcomes, but with reverse manner; the present study recorded 
elevation in iron levels in hepatitis C virus patients group comparison to controls group, the lowest copper levels and 
highest iron levels were observed in oldest patients.  
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Table 1: Levels (glL) of TSP, (µM) of MAD, (U/L) of Ceruloplasmin Oxidase Activity, and (glL) of Ceruloplasmin 
Concentration  in Patient of Hepatitis C Virus and control subjects (Mean±S.D.) 
Individuals 
Age 
(Years) 
 
Mean±S.D. 
Min-Max 
TSP Level 
(g/L) 
 
Mean±S.D. 
Min-Max 
MAD 
(µM) 
 
Mean±S.D. 
Min-Max 
Cp. Activity 
(U/L) 
 
Mean±S.D. 
Min-Max 
Cp. Level 
(g/L) 
 
Mean±S.D. 
Min-Max 
Cu Level 
(µg/ml) 
 
Mean±S.D. 
Min-Max 
Fe Level 
(µg/ml) 
 
Mean±S.D. 
Min-Max 
Patients 
(n=31) 
42.521 ±15.701 
23-67 
66.344±8.710 
53-81 
20.534±7.241 
9.375-28.513 
15.173±7.882 
8.263-23.991 
4.233±2.521 
3.535-9.530 
0.422±0.114 
0.133-0.753 
1.937±0.891 
1.071-3.181 
Controls 
(n=25) 
41.922±15.213 
19-62 
74.122±9.095 
59-83 
9.581±2.632 
3.325-14.381 
43.024±10.338 
15.705-63.169 
8. 942±4.852 
6.723-15.089 
0.692±0.291 
0.147 -1.112 
1.176±0.391 
0.900-1.483 
p-value 0.583 0.064 0.001 0.000 0.001 0.001 0.000 
 
In order to find the possible relation between the oxidation and antioxidation processes through the infection with C virus 
of hepatitis, the correlation between malondialdehyde as a profile to the peroxidation process, and ceruloplasmin enzyme  
(ceruloplasmin oxidase activity) as an agent of antioxidation was studied.  
As shown in Figure 2 A, the statistical analysis sucssed to illustrate a stronge negative correlation (r = - 0.813 at p<0.000) 
of malodialehyde levels to celoplasmin oxidase activity in sera of pateints, while no such correlation was observed when 
the compasion carried out in healthy control group (Figure 2 B).   
 
Fig. 2: Correlation of  Serum Malondialdehyde to the Ceruloplasmin Oxidase Activity in A: Patients of Hepatitis C 
Virus, and B: Healthy Individuals 
With the same manner, a significant negative correlation (r = 0.731 at p<0.001) between levels of serum malonaldehyde 
and ceruloplasmin concentration in patients group, as shown in Figure 3 A;  on the other hand, the healthy individuals 
group failed to illustrate same results to those in patients group when the correlation between serum malonaldehyde 
levels and ceruloplasmin concentration was carried out (Figure 3 B).  
 
Fig. 3: Correlation Of  Serum Malondialdehyde To The Ceruloplasmin Concentration In A: Patients of Hepatitis C 
Virus, and B: Healthy Individuals 
Results of hepatitis C infection parameters which evaluated in the current study, largely depends upon the patient’s age at 
infection and immune status as well as the level of hepatitis C replication. According to the previous studies, normally; total 
serum proteins level  decrease with the age progression; as well as this alteration (increase or decrease) in the protein 
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levels was recorded in numerous diseases [18-22]. The result of current study agreed with these findings, where the 
decreases in the total serum proteins' levels were proportion to the individuals' age (patients and controls), in addition to 
that the lowest proteins levels were recorded in sera of elderly individuals. 
Oxidative  damage by oxygen  free radicals such as superoxide anions  are  known to be one of the factors involved in the 
mechanisms of diseases[23]. During immune activation by viral entities, neutrophils and others cells produce ROS as a 
mechanism of signal amplification for protection [24]. ROS have also been implicated in a number of hepatic pathologies 
in exacerbating liver diseases[25], however, the oxidant production associated with immune reactions against viral 
hepatitis may lead to the formation of hepatocellular carcinoma, but unfortunately, approximately 10-40% of the patients 
with chronic HVC treat with the modern therapeutic models maintain the rate of sustained virologic response, therefore; 
detection of HVC infection and the effective advancement in the antiviral treatments against chronic HVC is necessary 
[26]. 
In previous study (personality work in our laboratory from 2010-2012) [22, 25], it showed a progressive rise of 
malondialdehyde level in serum samples for individuals (patients and healthy) with age. This relationship was highly 
significant. In the present work, there was a significant negative correlation between serum malondialdehyde level and the 
age progression (data not shown); this result agreed with the previous findings. On the other hand; malonaldehyde level in 
sera of patients was elevated (˷100% of cases) than those in sera of healthy individuals; according to this observation the 
lipid peroxidation status occurred in acute and chronic of infection with HCV, when compared this results with the previous 
study that deal with sera of patients suffered infection with  hepatitis virus type B, this study showed lipid peroxidation 
status didn’t occurred in the primary stage of infection with  hepatitis virus type B. This comparison illustrates important 
finding, we can exploit oxidative stress parameter (MDA) in differentiation  between hepatitis virus B and C types, 
to suggest the suitable therapy. This result is agreed with several studies that measured malonaldehyde level as a 
reflex for lipid peroxidation in numerous diseases [27, 28], while it disagreed with other studies, especially those with liver 
diseases [25, 29].  
Ceruloplasmin is a blue alpha-2 glycoprotein with a molecular weight of 132,000u, It binds 90-95% of blood plasma 
copper, has 6-7 Cu ions per molecule, and exhibits ferroxidase activity (an iron oxidase), amine oxidase activity, 
superoxidase activity, as well as it is involved in Cu transport and homeostasis [30]. 
The symptoms of many diseases that is characterized by low levels of ceruloplasmin with subsequent copper deposition in 
various tissues [31]. Results of present study agreed with these studies. In addition, ceruloplasmin is an acute phase 
reactant, whose concentration increases in inflammation, infection, and trauma, for these properties it is known as an 
antioxidant. This fact  boost the observations of the current work which explained the decreases in Cp activity and 
concentration in HCV serum to the liver cell damage which causes  countermarch in liver functions, then drop in synthesis 
of many proteins, ceruloplasmin may one of them. 
Concurrent study designed in order to investigate the roles and alterations of ceruloplasmin in acute and chronic HCV and 
compare its outcome with previous study that carried out on the chronic HBV samples.   
For the propose of arrive to integral understanding about the ceruloplasmin in HCV case, because copper and iron are 
linked to the ceruloplasmin [32, 33], their levels were determined. Results of the current study illustrated that decrease of 
copper level in serum of patients with hepatitis virus type C comparison to healthy controls, adverse result was found at 
the levels of iron determined. Highlight on the results of copper and iron levels in the patients’ sera illustrate that the 
decrease of copper concentration can be explained as a reflex to the decrease in the ceruloplasmin oxide activity and 
ceruloplasmin concentration as antioxidant agent in HCV, while, the literatures  recorded that  raises of the iron levels can 
be refer to the damage of liver cells [34, 35], these information support the hypothesis of the present work "liver cells may 
damage during different HCV infection stages". 
In order to prove the hypothesis of liver cells damage during the prim and advanced infection periods with hepatitis virus C 
type, the relationship of the malondialdehyde levels to ceruloplasmin oxidase activity, and ceruloplasmin concentration 
was carried out. The study outcome showed there are significant relation between these parameters; for that, we  can 
conclude that a decrease in the ceruloplasmin oxide activity and ceruloplasmin concentration  are reflex to arise in the lipid 
peroxidant products and an ambulance in the oxidation – antioxidation status. 
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